Our present results allow a cautious conclusion that the potent inhibition of glioblastoma cell viability may be achieved by combining MRP1 inhibitors with PDE inhibitors, especially the PDE10A inhibitor PF-2545920. Here, ALDH7A1 is linked to glioblastoma.